Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2003 May;74(5):597–601. doi: 10.1136/jnnp.74.5.597

Attenuated nuclear shrinkage in neurones with nuclear inclusions of SCA1 brains

U Nagaoka 1, T Uchihara 1, K Iwabuchi 1, H Konno 1, M Tobita 1, N Funata 1, S Yagishita 1, T Kato 1
PMCID: PMC1738416  PMID: 12700301

Abstract

Background: Spinocerebellar ataxia type 1 (SCA1) is one of the autosomal dominant neurodegenerative disorders commonly linked to pathological expansion of the CAG repeat of the relevant gene. Nuclear inclusions and neurodegeneration are both triggered by this pathological expansion of the CAG/polyglutamine repeat on ataxin-1, but it remains to be determined whether or not nuclear inclusion formation is associated with accelerated neurodegeneration.

Objective: To examine the influence of nuclear inclusions on nuclear size and deformity in human brains from patients suffering from SCA1.

Material: Pontine sections of brains obtained at necropsy from seven patients with SCA1 and five controls.

Methods: The size and deformity of each neuronal nucleus was quantified. Nuclei with and without inclusions were examined separately to assess the possible influence of nuclear inclusions on neurodegeneration.

Results: Nuclear shrinkage and deformity were more marked in SCA1 brains than in controls. This shrinkage was attenuated in neurones containing nuclear inclusions.

Conclusions: The existence of nuclear inclusions in SCA1 is presumably linked to a mechanism that attenuates rather than accelerates nuclear shrinkage. This in vivo finding may provide a clue to constructing a rational therapeutic strategy for combating neurodegeneration associated with nuclear inclusions.

Full Text

The Full Text of this article is available as a PDF (193.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bots G. T., Bruyn G. W. Neuropathological changes of the nucleus accumbens in Huntington's chorea. Acta Neuropathol. 1981;55(1):21–22. doi: 10.1007/BF00691525. [DOI] [PubMed] [Google Scholar]
  2. Cummings C. J., Mancini M. A., Antalffy B., DeFranco D. B., Orr H. T., Zoghbi H. Y. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet. 1998 Jun;19(2):148–154. doi: 10.1038/502. [DOI] [PubMed] [Google Scholar]
  3. Cummings C. J., Reinstein E., Sun Y., Antalffy B., Jiang Y., Ciechanover A., Orr H. T., Beaudet A. L., Zoghbi H. Y. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron. 1999 Dec;24(4):879–892. doi: 10.1016/s0896-6273(00)81035-1. [DOI] [PubMed] [Google Scholar]
  4. Davies S. W., Turmaine M., Cozens B. A., DiFiglia M., Sharp A. H., Ross C. A., Scherzinger E., Wanker E. E., Mangiarini L., Bates G. P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 1997 Aug 8;90(3):537–548. doi: 10.1016/s0092-8674(00)80513-9. [DOI] [PubMed] [Google Scholar]
  5. Fujigasaki H., Uchihara T., Koyano S., Iwabuchi K., Yagishita S., Makifuchi T., Nakamura A., Ishida K., Toru S., Hirai S. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains. Exp Neurol. 2000 Oct;165(2):248–256. doi: 10.1006/exnr.2000.7479. [DOI] [PubMed] [Google Scholar]
  6. Kaytor M. D., Warren S. T. Aberrant protein deposition and neurological disease. J Biol Chem. 1999 Dec 31;274(53):37507–37510. doi: 10.1074/jbc.274.53.37507. [DOI] [PubMed] [Google Scholar]
  7. Kim M., Lee H. S., LaForet G., McIntyre C., Martin E. J., Chang P., Kim T. W., Williams M., Reddy P. H., Tagle D. Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J Neurosci. 1999 Feb 1;19(3):964–973. doi: 10.1523/JNEUROSCI.19-03-00964.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Klement I. A., Skinner P. J., Kaytor M. D., Yi H., Hersch S. M., Clark H. B., Zoghbi H. Y., Orr H. T. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell. 1998 Oct 2;95(1):41–53. doi: 10.1016/s0092-8674(00)81781-x. [DOI] [PubMed] [Google Scholar]
  9. Kuemmerle S., Gutekunst C. A., Klein A. M., Li X. J., Li S. H., Beal M. F., Hersch S. M., Ferrante R. J. Huntington aggregates may not predict neuronal death in Huntington's disease. Ann Neurol. 1999 Dec;46(6):842–849. [PubMed] [Google Scholar]
  10. Ona V. O., Li M., Vonsattel J. P., Andrews L. J., Khan S. Q., Chung W. M., Frey A. S., Menon A. S., Li X. J., Stieg P. E. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature. 1999 May 20;399(6733):263–267. doi: 10.1038/20446. [DOI] [PubMed] [Google Scholar]
  11. Orr H. T., Chung M. Y., Banfi S., Kwiatkowski T. J., Jr, Servadio A., Beaudet A. L., McCall A. E., Duvick L. A., Ranum L. P., Zoghbi H. Y. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet. 1993 Jul;4(3):221–226. doi: 10.1038/ng0793-221. [DOI] [PubMed] [Google Scholar]
  12. Roos R. A., Bots G. T. Nuclear membrane indentations in Huntington's chorea. J Neurol Sci. 1983 Sep;61(1):37–47. doi: 10.1016/0022-510x(83)90053-9. [DOI] [PubMed] [Google Scholar]
  13. Saudou F., Finkbeiner S., Devys D., Greenberg M. E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 1998 Oct 2;95(1):55–66. doi: 10.1016/s0092-8674(00)81782-1. [DOI] [PubMed] [Google Scholar]
  14. Sisodia S. S. Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental, or beneficial? Cell. 1998 Oct 2;95(1):1–4. doi: 10.1016/s0092-8674(00)81743-2. [DOI] [PubMed] [Google Scholar]
  15. Takahashi H., Egawa S., Piao Y. S., Hayashi S., Yamada M., Shimohata T., Oyanagi K., Tsuji S. Neuronal nuclear alterations in dentatorubral-pallidoluysian atrophy: ultrastructural and morphometric studies of the cerebellar granule cells. Brain Res. 2001 Nov 16;919(1):12–19. doi: 10.1016/s0006-8993(01)02986-9. [DOI] [PubMed] [Google Scholar]
  16. Takahashi J., Fukuda T., Tanaka J., Minamitani M., Fujigasaki H., Uchihara T. Neuronal intranuclear hyaline inclusion disease with polyglutamine-immunoreactive inclusions. Acta Neuropathol. 2000 May;99(5):589–594. doi: 10.1007/s004010051166. [DOI] [PubMed] [Google Scholar]
  17. Takahashi J., Tanaka J., Arai K., Funata N., Hattori T., Fukuda T., Fujigasaki H., Uchihara T. Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease. J Neuropathol Exp Neurol. 2001 Apr;60(4):369–376. doi: 10.1093/jnen/60.4.369. [DOI] [PubMed] [Google Scholar]
  18. Uchihara Toshiki, Iwabuchi Kiyoshi, Funata Nobuaki, Yagishita Saburo. Attenuated nuclear shrinkage in neurons with nuclear aggregates--a morphometric study on pontine neurons of Machado-Joseph disease brains. Exp Neurol. 2002 Nov;178(1):124–128. doi: 10.1006/exnr.2002.8028. [DOI] [PubMed] [Google Scholar]
  19. Uchihara Toshiki, Tanaka Junichi, Funata Nobuaki, Arai Kimihito, Hattori Takamichi. Influences of intranuclear inclusion on nuclear size - morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases. Acta Neuropathol. 2002 Sep 13;105(2):103–108. doi: 10.1007/s00401-002-0614-9. [DOI] [PubMed] [Google Scholar]
  20. Yamamoto A., Lucas J. J., Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell. 2000 Mar 31;101(1):57–66. doi: 10.1016/S0092-8674(00)80623-6. [DOI] [PubMed] [Google Scholar]
  21. Zoghbi H. Y., Orr H. T. Glutamine repeats and neurodegeneration. Annu Rev Neurosci. 2000;23:217–247. doi: 10.1146/annurev.neuro.23.1.217. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES